Tianjin Pharmaceutical Da Ren Tang Group Corporation LimitedSSE: 600329

Announcement on Convening the Q3 2024 Performance Briefing

Dec 5, 2024 · Issued by Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited via Shanghai Stock Exchange

Filed with SSE · Dec 5, 2024

On 6ix: 6ix.com/news/announcement-on-convening-the-q3-2024-performance-briefing-27

Announcement on Convening the Q3 2024 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited on 6ix

Earlier from Tianjin Pharmaceutical Da Ren Tang

Announcement on Resignation and By-election of SupervisorNov 27, 2024
Announcement on Resolution of the 2nd Extraordinary General Meeting in 2024Nov 23, 2024
Indicative Announcement on Convening the 2nd Extraordinary General Meeting in 2024Nov 19, 2024
Notice on Convening the 3rd Extraordinary General Meeting in 2024Nov 15, 2024
Announcement on the Achievements of Lifting Restriction Conditions in the 3rd Restricted Stock Trading Period of the 2019 A-Share Restricted Share PlanNov 12, 2024

Later from Tianjin Pharmaceutical Da Ren Tang

Announcement on Adding Extraordinary Proposal to the 3rd Extraordinary General Meeting in 2024Dec 7, 2024
Announcement on Resignation of General ManagerDec 11, 2024
Announcement on Unlocking and Listing of Restricted Shares for the 3rd Restricted Stock Trading Period of the 2019 A-Share Restricted Stock PlanDec 21, 2024
Indicative Announcement on Convening the 3rd Extraordinary General Meeting in 2024Dec 25, 2024
Announcement on the Completion of Capital Increase for Jinyao Pacific Pharmaceutical Co., Ltd. and Related Party TransactionsDec 27, 2024

All Tianjin Pharmaceutical Da Ren Tang news releases

Follow Tianjin Pharmaceutical Da Ren Tang into a list and get an email when it puts out news.

Follow Tianjin Pharmaceutical Da Ren Tang